17 March 2017
The Ministry of Industry and Trade of Russia will make changes to the List of bio-targets for developing the analogs of innovative medicinal products that are similar and improved in terms of their pharmacotherapeutic effect.
The need to amend the document is associated with the increased opportunities for the Russian organizations developing narcotic and immunobiological medicinal products to receive subsidies from the federal budget. At this point, the list of bio-targets includes 96 items.
The draft regulatory legal act is expected to come into force in April 2017.
Print14 March 2024
26 February 2024
NovaMedica team wishes you a Merry Christmas and a Happy New Year!
26 December 2023
16 May 2024
Alcohol-containing non-food products in Russia may receive labeling
16 May 2024
Foreign pharma company reevaluates Russian market
15 May 2024
Oriental Medicine Center in Buryatia to work with Chinese university
15 May 2024